TScan Therapeutics Inc (TCRX)
NASDAQ
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
Cash from Operating Activities | -66.5M | -23.59M | -45.61M | -37.59M | -61.36M | -29.27M | -55.49M | -83.41M |
Cash from Investing Activities | -4.23M | -838k | -1.26M | -62.67M | -60.76M | 36.16M | 2.45M | -79.91M |
Cash from Financing Activities | 29.36M | N/A | 135.68M | 135.42M | 135.44M | 258k | 161.85M | 163.08M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Cash from Operating Activities | -12.52M | -3.02M | -48.68M | -66.5M | -61.36M |
Cash from Investing Activities | -1.25M | -4.24M | -9.94M | -4.23M | -60.76M |
Cash from Financing Activities | 34.81M | 288k | 189.67M | 29.36M | 135.44M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.